Loading...
Loading...
Predictmedix Inc.
Predictmedix Inc.. Spoken Alpha tracks PMEDF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks PMEDF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PMEDF.
curl https://api.spokenalpha.com/v1/companies/PMEDF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.58 | $2.36 | +9.4% | -4.5% | -5.9% |
| Q4 FY2026 | $2.57 | $2.33 | +10.3% | +2.7% | +4.0% |
| Q3 FY2026 | $2.78 | $2.46 | +12.9% | -0.6% | -0.7% |
| Q2 FY2026 | $2.76 | $2.60 | +6.3% | -1.6% | -0.2% |
| Q1 FY2025 | $2.90 | $2.53 | +14.6% | -0.3% | -1.4% |
| Q4 FY2025 | $2.75 | $2.63 | +4.5% | -3.2% | -5.2% |
| Q3 FY2025 | $3.00 | $2.60 | +15.4% | -3.0% | -0.7% |
| Q2 FY2025 | $2.79 | $2.50 | +11.7% | +1.4% | +0.9% |
| Q1 FY2024 | $2.76 | $2.70 | +2.3% | -3.1% | -2.5% |
| Q4 FY2024 | $2.95 | $2.65 | +11.5% | +4.4% | +6.5% |